Bird & Bird advises Bio-Medical Research Ltd. on the sale of its wholly owned German subsidary

05 February 2015

Bird & Bird LLP advised the Irish based medical device company Bio-Medical Research Ltd on both the restructuring of its wholly owned German subsidiary, Bio-Medical Research GmbH, and on the subsequent sale of all shares in this subsidiary to Germany based company Schwa-Medico Group.

Bio-Medical Research Limited develops, manufactures and distributes medical devices for muscle strengthening and pain relief through its divisions SLENDERTONE and neurotech. The company offers health and fitness products as well as neuromuscular stimulators for pain therapy and rehabilitation.

The advice through Bird & Bird LLP covered the preparation and implementation of an intragroup asset deal in which Bio-Medical Research GmbH sold and transferred its urological and gynaecological business division to another German subsidiary (BMR Health GmbH).

The remaining orthopaedic business in Germany, Austria, and Switzerland, which provides electrical stimulators for pain management and rehabilitation, was then sold to Schwa-Medico Group through a share deal.

Bio-Medical Research Ltd  has been advised by the following Bird & Bird lawyers: Partner Stefan Münch (Corporate/M&A, lead partner), Dr. Alexander Duisberg (IT, data protection), Dr. Markus Körner (IP, all Munich) and Michael Jünemann (Banking and Finance, Frankfurt), Counsel Peter Hützen (Employment, Düsseldorf), Associates Stephan Kübler, Kevin Ruben (both Corporate/M&A) and Thomas Urband (IP / all Munich).

For more information please contact:

Carola Heinig, Marketing Manager Germany

T +49 (0) 211 2005 6243, email: carola.heinig@twobirds.com